MDGL

SEC source: 0001628280-26-044290 · wk-form4_1781813560.xml · nonDerivative · entry 1

Brennan Daniel J. · CIK 0001595612 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,371

F1 · kind: Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date.

SEC source: 0001628280-26-044307 · wk-form4_1781813798.xml · derivative · entry 2

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 766

Underlying: Common Stock · 766 shares

Expires 2036-06-17

F2 · derivative.exercise_date: The option vests as to 100% of underlying shares on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date.

SEC source: 0001628280-26-044307 · wk-form4_1781813798.xml · nonDerivative · entry 1

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,081

F1 · kind: Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date.

SEC source: 0001628280-26-039653 · wk-form4_1780357747.xml · nonDerivative · entry 1

Soergel David · CIK 0001591475 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,033

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2026.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 12

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,015

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.68 to $520.28, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 11

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,095

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.30 to $519.29, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 10

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,877

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.28 to $518.27, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 9

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,374

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.28 to $517.27, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 8

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,097

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.26 to $516.22, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 7

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,754

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.17 to $515.16, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 6

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,097

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 5

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,137

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.91 to $512.88, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 4

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,576

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.89 to $511.87, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 3

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,186

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.89 to $510.85, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 2

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,337

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.11 to $508.89, inclusive.

SEC source: 0001628280-26-037830 · wk-form4_1779487311.xml · nonDerivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,657

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $506.42 to $507.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

SEC source: 0001628280-26-036078 · wk-form4_1779140170.xml · nonDerivative · entry 1

Soergel David · CIK 0001591475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,075

F1 · kind: This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 13

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,490

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 12

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,530

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $436.46 to $436.92, inclusive.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 11

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,610

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $435.26 to $435.37, inclusive.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 10

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,690

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $433.82 to $434.58, inclusive.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 9

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,850

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $432.41 to $432.99, inclusive.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 8

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,966

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $430.66 to $431.04, inclusive.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 7

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,086

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 6

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,126

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $428.51 to $429.24, inclusive.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 5

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,286

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $427.50 to $428.19, inclusive.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 4

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,366

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $426.46 to $427.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 3

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,786

F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 2

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,826

F2 · kind: This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-26-015769 · wk-form4_1772840956.xml · nonDerivative · entry 2

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,829

F2 · kind: This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-26-015763 · wk-form4_1772840042.xml · nonDerivative · entry 2

Kelley Shannon T · CIK 0002034056 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,138

F2 · kind: This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-26-015758 · wk-form4_1772838950.xml · nonDerivative · entry 2

Huntsman Carole · CIK 0002001571 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,692

F2 · kind: This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-26-015736 · wk-form4_1772838445.xml · nonDerivative · entry 1

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 452,213

F1 · kind: This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · derivative · entry 14

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,519

Underlying: Common Stock · 6,519 shares

Expires 2036-03-04

F12 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-015775 · wk-form4_1772842708.xml · nonDerivative · entry 1

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,472

F1 · kind: Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-015769 · wk-form4_1772840956.xml · derivative · entry 3

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,743

Underlying: Common Stock · 18,743 shares

Expires 2036-03-04

F3 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-015769 · wk-form4_1772840956.xml · nonDerivative · entry 1

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,492

F1 · kind: Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-015763 · wk-form4_1772840042.xml · derivative · entry 3

Kelley Shannon T · CIK 0002034056 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,022

Underlying: Common Stock · 5,022 shares

Expires 2036-03-04

F3 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-015763 · wk-form4_1772840042.xml · nonDerivative · entry 1

Kelley Shannon T · CIK 0002034056 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,498

F1 · kind: Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-015758 · wk-form4_1772838950.xml · derivative · entry 3

Huntsman Carole · CIK 0002001571 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,986

Underlying: Common Stock · 4,986 shares

Expires 2036-03-04

F3 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-015758 · wk-form4_1772838950.xml · nonDerivative · entry 1

Huntsman Carole · CIK 0002001571 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,111

F1 · kind: Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-015722 · wk-form4_1772837756.xml · derivative · entry 2

Soergel David · CIK 0001591475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,467

Underlying: Common Stock · 5,467 shares

Expires 2036-03-04

F2 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-015722 · wk-form4_1772837756.xml · nonDerivative · entry 1

Soergel David · CIK 0001591475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,919

F1 · kind: Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0001628280-26-013394 · wk-form4_1772490753.xml · nonDerivative · entry 1

Dier Mardi · CIK 0001574591 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,257

F1 · kind: This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-26-011211 · wk-form4_1771970943.xml · derivative · entry 2

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

SEC source: 0001628280-26-011211 · wk-form4_1771970943.xml · nonDerivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,697

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-003491 · wk-form4_1769468543.xml · derivative · entry 2

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2027-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

SEC source: 0001628280-26-003491 · wk-form4_1769468543.xml · nonDerivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,197

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-003482 · wk-form4_1769467117.xml · nonDerivative · entry 2

Huntsman Carole · CIK 0002001571 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,122

F2 · kind: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.

SEC source: 0001628280-26-003482 · wk-form4_1769467117.xml · nonDerivative · entry 1

Huntsman Carole · CIK 0002001571 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,692

F1 · kind: The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.